Table 5.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Kidney Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		9,738	10,360	10,645	11,072	11,382	11,693	12,418	12,696	13,542	14,226
Tx With Follow-up Immunosuppression Info		8,426	9,074	9,332	9,858	10,264	10,659	11,300	11,631	12,325	13,127
Corticosteroids	Category Usage	99.5%	99.7%	99.6%	99.5%	99.2%	99.1%	98.9%	98.5%	96.8%	95.7%
	Steroids	99.5%	99.7%	99.6%	99.5%	99.2%	99.1%	98.9%	98.5%	96.8%	95.7%
Cyclosporine	Category Usage	95.8%	96.4%	92.9%	88.9%	80.8%	74.5%	68.6%	63.4%	53.1%	39.4%
	Cyclosporin	94.9%	94.5%	89.8%	49.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	2.2%	4.7%	7.9%	41.8%	14.2%	9.2%	8.4%	8.6%	5.1%	3.3%
	Neoral	0.2%	0.4%	1.1%	40.1%	73.2%	69.3%	65.0%	59.0%	48.1%	31.3%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%	4.3%	8.6%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.2%	0.3%
Tacrolimus	Category Usage	3.3%	3.7%	9.8%	14.3%	22.1%	29.0%	36.9%	42.7%	52.5%	63.6%
	FK506	3.3%	3.7%	9.8%	14.3%	22.1%	29.0%	36.9%	42.7%	52.5%	63.6%
Antimetabolites	Category Usage	87.8%	88.2%	85.5%	74.0%	69.6%	88.2%	88.4%	88.6%	83.9%	83.3%
	Azathioprine	87.2%	87.2%	84.9%	63.1%	30.3%	20.3%	13.3%	10.9%	7.6%	6.0%
	Mycophenolate mofetil	1.1%	1.8%	1.7%	14.6%	42.9%	72.4%	79.1%	81.8%	79.4%	79.8%
Other	Category Usage	0.4%	0.2%	0.7%	0.6%	1.5%	2.5%	3.7%	5.5%	17.0%	21.5%
	Rapamycin	0.0%	0.0%	0.3%	0.3%	1.2%	2.3%	3.4%	5.2%	16.7%	21.4%
	Cytoxan	0.3%	0.2%	0.4%	0.3%	0.3%	0.2%	0.3%	0.4%	0.3%	0.2%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.